1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)
oleh: Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-12-01 |
Deskripsi
No description available for this item.